Question 1

A medical device company is undergoing an ISO 13485:2016 audit. The Lead Auditor observes that the company uses a software program to manage customer complaints and track corrective actions. The software program allows users to easily generate reports and analyze trends in customer feedback. The manufacturer has performed initial validation and has documented a process for regular preventative maintenance of the software. What additional action must be verified by the Lead Auditor to ensure compliance?

Options :

A : The Lead Auditor should verify the integrity of the software is maintained and secured against unauthorized changes.

B : The Lead Auditor should verify that the software generates aesthetically pleasing and easily understandable reports.

C : The Lead Auditor should verify the software developers hold an ISO 13485:2016 Lead Auditor certification.

D : The Lead Auditor should verify the software is also used for other business functions such as marketing.

Answer: A

Question 2

During an ISO 13485:2016 audit of a medical device company, the Lead Auditor discovers that the company has implemented a comprehensive training program for its employees. The program covers various aspects of the QMS, including document control, CAPA, and risk management. However, the effectiveness of the training is solely measured through post-training quizzes, with no documented evidence of how the learned knowledge and skills are applied in the employees' actual job performance. As a Lead Auditor, what is your PRIMARY concern?

Options :

A : The lack of a defined process for verifying the effectiveness of the training could lead to employees not applying the learned knowledge and skills in their work, potentially impacting product quality and safety.

B : The exclusive reliance on post-training quizzes is sufficient to demonstrate training effectiveness, as long as the quiz questions are comprehensive and cover all relevant aspects of the QMS.

C : The absence of documented evidence of training effectiveness is not a significant concern, as long as the training program is well-structured and covers all required topics.

D : The company should focus on improving the content of the post-training quizzes to better assess the employees' understanding of the QMS requirements.

Answer: A

Question 3

A medical device company manufactures Class IIa devices and is undergoing an ISO 13485:2016 audit. During a review of the organization's change control process, the Lead Auditor discovers that the company's impact assessment for product changes only focuses on assessing the impact to the design and manufacturing processes. There is no documented procedure for assessing the impact of the change on device labeling, including IFU (Instructions for Use), warnings and precautions, symbols, or any regulatory labeling requirements. As the Lead Auditor, what is the MOST appropriate action to take?

Options :

A : Accept the existing procedure, as it adequately covers the primary aspects of product change impact.

B : Issue a finding related to inadequate consideration of change impact on the risk management file.

C : Inquire if all change control personnel have been trained on identifying labeling requirements.

D : Issue a finding related to inadequate consideration of change impact on labeling.

Answer: D

Question 4

A medical device company has implemented a system for monitoring and measuring key processes within its Quality Management System (QMS). The system generates various performance metrics, which are regularly reviewed by management. However, the Lead Auditor discovers that the company has not established specific, measurable, achievable, relevant, and time-bound (SMART) objectives for these metrics. As a Lead Auditor, what is the MOST significant concern?

Options :

A : The lack of SMART objectives indicates a potential lack of commitment to continual improvement within the QMS.

B : Without SMART objectives, it will be difficult to determine whether the monitoring and measurement system is effective in achieving its intended purpose.

C : The absence of SMART objectives will likely lead to inconsistencies in data collection and analysis across different departments.

D : The company is not fully utilizing the available data to identify areas for improvement and optimize process performance.

Answer: B

Question 5

A medical device company is undergoing an ISO 13485:2016 audit. The company utilizes a cloud-based Enterprise Resource Planning (ERP) system for managing its inventory, purchasing, and production planning. The company claims that since the cloud provider is ISO 27001 certified, they do not need to perform their own validation of the software's suitability for managing their QMS data. As a Lead Auditor, what aspect of validation and security is MOST important to investigate?

Options :

A : Confirm that the cloud provider-s ISO 27001 certification covers the specific services used by the medical device company.

B : Verify that the medical device company has a documented procedure for data backup and disaster recovery in case of a cloud outage.

C : Assess whether the medical device company has performed its own risk assessment to identify potential risks related to data integrity, data privacy and data availability when using the ERP.

D : Review the contract between the medical device company and the cloud provider to ensure it clearly defines responsibilities for data security and data privacy.

Answer: C

Free ISO-QMS-13485 Mock Exam – Practice Online Confidently

Buying Options: